Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
London, England-based Smith & Nephew and Austin-based ArthroCare Corp. have received early termination of the waiting period mandated by antitrust law, satisfying one of the requirements for Smith & Nephew's acquisition of AthroCare.
Mundelein, Ill.-based Medline will have exclusive distribution rights of King of Prussia, Pa.-based Devon Medical Products that treat lymphedema.
Roswell, Ga.-based Kimberly-Clark Health Care and St. Paul, Minn.-based 3M have formed an alliance to provide surgical and infection prevention solutions to healthcare facilities.
The U.S. Food and Drug Administration has approved a Supplemental New Drug Application for Bristol-Myers Squibb/Pfizer's Eliquis (apixaban) as a preventative measure against potential pulmonary embolism-causing blood clots for patients who have undergone hip or knee replacement therapy, according to…
Dublin, Ireland-based Shire Pharmaceuticals has issued a voluntary recall on three lots of VPRIV, a long-term intravenous enzyme replacement therapy for patients with type 1 Gaucher disease, due to stainless steel and barium sulfate particulate matter found in a few…
Stamford, Conn.-based Purdue Pharma, the manufacturer of OxyContin, announced successful results from a stage three clinical trial on its hydrocodone drug designed to prevent misuse and abuse of the drug.
Waukesha County, Wis.-based ProHealth Care has selected Mundelein, Ill.-based Medline as its exclusive medical and surgical supply distribution partner.
The U.S. Food and Drug Administration approved Herstal, Belgium-based STX-Med to market Cefaly, the first medical device offering preventative treatment for migraines.
Dallas-based MD Buyline has released a set of product enhancements for its Buyline Purchased Services Program that allows PSP subscribers more customized interaction with their purchased services.
Phoenix-based SharedClarity, a subsidiary of Minneapolis-based UnitedHealth Group, has signed agreements with Medtronic and Abbott Laboratories to buy the majority of its heart stents from the device companies at highly discounted prices for its 135 network hospitals, according to a…